Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates
US8580737B2 · kind B2 · utility
1Cited by
9References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 12, 2012 |
| Grant date | Nov 12, 2013 |
| Priority date | — |
| Expiry date | Sep 12, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The field of the invention is the treatment of acquired bleeding, a clinical condition associated with severe traumatic, peri- or post-operative bleeding. A novel treatment is proposed in which synergistic pro-coagulatory properties of Prothrombin Complex Concentrates (PCC) together with medicaments comprising FVIII and/or vWF are exploited.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.